Transition Bio is Drug Discovery in United States that focus on protein biophysics platforms business. Founded in 2020. They cover business area such as operator, a hypothesis-free drug discovery, diagnostic, platform, human health care advancement, droplet microfluidic approach, condensate, unprecedented precision, medical practitioner, molecular detail.
2020
( 4 years old in 2024 )
Protein Biophysics Platforms
-
Cambridge, MA
United States
Private
operatora hypothesis-free drug discoverydiagnosticplatformhuman health care advancementdroplet microfluidic approachcondensateunprecedented precisionmedical practitionermolecular detail
* We use standard office opening hours in near Transition Bio's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Transition Bio is Drug Discovery business from United States that founded in 2020 (4 years old in 2024), Transition Bio business is focusing on Protein Biophysics Platforms.
Transition Bio headquarter office and corporate office address is located in Cambridge, MA United States.
Transition Bio was founded in United States.
In 2024, Transition Bio is currently focus on protein biophysics platforms sector.
Above is snippet of Google Trends for "protein biophysics platforms" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Transition Bio, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
